A Dose Finding Study of Preladenant (SCH 420814) for the Treatment of Parkinson's Disease (PD) in Japanese Patients (P06402)

NCT01294800 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

450

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Preladenant
DRUG: Placebo tablet to match Preladenant

Sponsor

Merck Sharp & Dohme LLC